Sound waves and Light-Activated drug tested against aggressive brain tumors
NCT ID NCT04559685
First seen May 16, 2026 · Last updated May 16, 2026
Summary
This early-phase study tested a new approach called sonodynamic therapy for people with recurrent high-grade glioma, a fast-growing brain tumor. Participants received a drug called ALA followed by focused ultrasound to activate it. The goal was to check safety and see if the treatment caused biological changes in the tumor. The study was terminated early, and results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH-GRADE GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
St. Joseph's Hospital and Medical Center
Phoenix, Arizona, 85013, United States
Conditions
Explore the condition pages connected to this study.